These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 19241077
21. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response. Okafuji K, Kaku K, Seguchi M, Tanaka H, Azuno Y, Kaneko T. Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239 [Abstract] [Full Text] [Related]
22. Erythroid and megakaryocytic differentiation of K562 erythroleukemic cells by monochloramine. Ogino T, Kobuchi H, Fujita H, Matsukawa A, Utsumi K. Free Radic Res; 2014 Mar; 48(3):292-302. PubMed ID: 24237253 [Abstract] [Full Text] [Related]
23. Inducers of erythroid differentiation in K562 human leukemia cells. Rowley PT, Ohlsson-Wilhelm BM, Farley BA, LaBella S. Exp Hematol; 1981 Jan; 9(1):32-7. PubMed ID: 6940756 [Abstract] [Full Text] [Related]
24. Oral small-molecule tyrosine kinase inhibitor midostaurin (PKC412) inhibits growth and induces megakaryocytic differentiation in human leukemia cells. Huang YC, Chao DK, Clifford Chao KS, Chen YJ. Toxicol In Vitro; 2009 Sep; 23(6):979-85. PubMed ID: 19573588 [Abstract] [Full Text] [Related]
25. Cisplatin-induced erythroid differentiation in K562 cells: modulation of transferrin receptor. Parodi MT, Tonini GP, Bologna R, Franchini E, Cornaglia-Ferraris P. Boll Ist Sieroter Milan; 1988 Sep; 67(2):142-8. PubMed ID: 3228498 [Abstract] [Full Text] [Related]
26. Multiple differentiation programs in K562 erythroleukemia cells and their regulation. Horton MA, Cedar SH, Maryanka D, Mills FC, Turberville C. Prog Clin Biol Res; 1983 Sep; 134():305-22. PubMed ID: 6582521 [Abstract] [Full Text] [Related]
27. Establishment and characterization of a new erythroblastic leukemia cell line, EEB: phosphatidylglucoside-mediated erythroid differentiation and apoptosis. Kawano-Yamamoto C, Muroi K, Nagatsuka Y, Higuchi M, Kikuchi S, Nagai T, Hakomori SI, Ozawa K. Leuk Res; 2006 Jul; 30(7):829-39. PubMed ID: 16332389 [Abstract] [Full Text] [Related]
28. Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3. Tringali C, Lupo B, Cirillo F, Papini N, Anastasia L, Lamorte G, Colombi P, Bresciani R, Monti E, Tettamanti G, Venerando B. Cell Death Differ; 2009 Jan; 16(1):164-74. PubMed ID: 18820643 [Abstract] [Full Text] [Related]
29. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent. Sato S, Tomoyasu S, Okabe-Kado J, Hozumi M, Tsuruoka N, Nakai S, Adachi M, Honma Y. Exp Hematol; 1996 Jan; 24(1):37-42. PubMed ID: 8536790 [Abstract] [Full Text] [Related]
30. Hydroxyurea induces a senescence-like change of K562 human erythroleukemia cell. Park JI, Jeong JS, Han JY, Kim DI, Gao YH, Park SC, Rodgers GP, Kim IH. J Cancer Res Clin Oncol; 2000 Aug; 126(8):455-60. PubMed ID: 10961388 [Abstract] [Full Text] [Related]
31. Protein content and number of nucleolar organizer regions are enhanced during phorbol ester-induced differentiation of cultured human megakaryocytic cells. Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C. Anticancer Res; 1999 Aug; 19(4B):3229-35. PubMed ID: 10652616 [Abstract] [Full Text] [Related]
32. Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells. Petrak J, Myslivcova D, Man P, Cmejlova J, Cmejla R, Vyoral D. Exp Hematol; 2007 Feb; 35(2):193-202. PubMed ID: 17258068 [Abstract] [Full Text] [Related]
33. HEL and K562 cells: analysis of proteins by two-dimensional gel electrophoresis and comparison to erythroid and nonerythroid cells. Larson AE, Papayannopoulou T. Exp Hematol; 1985 Feb; 13(2):129-35. PubMed ID: 3855756 [Abstract] [Full Text] [Related]
34. The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells. Shen HW, Chen YL, Chern CY, Kan WM. Prostaglandins Other Lipid Mediat; 2007 May; 83(3):231-6. PubMed ID: 17481561 [Abstract] [Full Text] [Related]
35. Lycopene affects proliferation and apoptosis of four malignant cell lines. Salman H, Bergman M, Djaldetti M, Bessler H. Biomed Pharmacother; 2007 Jul; 61(6):366-9. PubMed ID: 17448625 [Abstract] [Full Text] [Related]
36. JAS-R, a new megakaryo-erythroid leukemic cell line that secretes erythropoietin. Sekikawa T, Iwase S, Saito S, Arakawa Y, Agawa M, Horiguchi-Yamada J, Yamada H. Anticancer Res; 2006 Jul; 26(2A):843-50. PubMed ID: 16619478 [Abstract] [Full Text] [Related]
37. Sedimentation field flow fractionation to study human erythroleukemia cell megakaryocytic differentiation after short period diosgenin induction. Léger DY, Battu S, Liagre B, Cardot PJ, Beneytout JL. J Chromatogr A; 2007 Jul 20; 1157(1-2):309-20. PubMed ID: 17499257 [Abstract] [Full Text] [Related]
39. Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1. Gannon AM, Turner EC, Reid HM, Kinsella BT. J Mol Biol; 2009 Nov 20; 394(1):29-45. PubMed ID: 19747485 [Abstract] [Full Text] [Related]
40. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis. Olthof SG, Fatrai S, Drayer AL, Tyl MR, Vellenga E, Schuringa JJ. Stem Cells; 2008 Jul 20; 26(7):1732-42. PubMed ID: 18436865 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]